"10.1371_journal.pone.0116079","plos one","2015-01-20T00:00:00Z","Zhirong Yang; Jing Wang; Weiwei Wang; Yuelun Zhang; Lizhong Han; Yuan Zhang; Xiaolu Nie; Siyan Zhan","Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China; Shantou-Oxford Clinical Research Unit, Shantou University Medical College, Shantou, Guangdong, China; Department of Clinical Microbiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada","Conceived and designed the experiments: ZY LH SZ. Performed the experiments: ZY JW WW Yuelun Zhang Yuan Zhang XN. Analyzed the data: ZY JW. Contributed reagents/materials/analysis tools: ZY JW WW Yuelun Zhang Yuan Zhang XN. Wrote the paper: ZY JW LH SZ.","This study was partly supported by MedImmune LLC, a wholly owned subsidiary of AstraZeneca, mainly for literature search and data collection. The funding was received directly by Peking University Health Science Center. None was paid individually to the researchers in this study for any employment or consultancy for the company. Antibiotics discussed in this review were not the patents of the company or its products in development or on market. There is no further relevant information about the conflicts of interest to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","01","Zhirong Yang","ZY",8,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
